The body's clotting system is designed to quickly stop bleeding following injury. When a blood vessel is damaged, von Willebrand factor helps platelets attach to the injured area and form an initial clot. In dogs with von Willebrand Disease Type 2, the structure and function of this protein are altered, reducing its effectiveness. As a result, affected dogs may experience prolonged bleeding even after minor injuries or routine surgical procedures.
Clinical signs of vWD2 can vary in severity depending on the individual dog and the degree of clotting impairment. Common symptoms include frequent nosebleeds, excessive bleeding from small cuts, prolonged bleeding after surgery or injury, bleeding from the gums, blood in urine or stool, and easy bruising. Some affected dogs may not show obvious signs until they undergo a surgical procedure such as spaying, neutering, or dental work. In severe cases, uncontrolled bleeding can become a medical emergency requiring immediate veterinary attention.
The vWD2 DNA Health Test is designed to identify the specific genetic mutation associated with von Willebrand Disease Type 2. Testing is simple, safe, and non-invasive, requiring either a cheek swab or blood sample. The collected sample is analyzed in a specialized laboratory to determine the dog's genetic status. Because DNA remains unchanged throughout life, testing can be performed at any age, including in puppies before symptoms become apparent.
Results are generally reported in one of three categories:
- Clear (Normal): The dog does not carry the vWD2 mutation and cannot pass it to offspring.
- Carrier: The dog carries one copy of the mutation. Depending on the inheritance pattern and individual circumstances, carriers may have mild clotting abnormalities and can pass the mutation to future generations.
- Affected/At Risk: The dog carries the disease-associated mutation and has a significantly increased likelihood of developing von Willebrand Disease Type 2 and experiencing abnormal bleeding episodes.
Genetic testing for vWD2 provides valuable information for breeders, veterinarians, and dog owners. Breeders can use test results to make informed mating decisions that help reduce the prevalence of the disorder while maintaining healthy genetic diversity within the breed population. Responsible breeding strategies can significantly decrease the number of affected puppies born in future generations.
For dog owners, knowing a dog's genetic status allows for proactive healthcare management. Dogs identified as affected or at risk may benefit from additional precautions before surgery, dental procedures, or other medical treatments that could result in bleeding. Veterinarians can use this information to develop appropriate treatment plans and prepare for potential clotting complications.
The von Willebrand Disease Type 2 (vWD2) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine hematological health, and helps reduce the impact of this inherited bleeding disorder. Through early detection and informed breeding decisions, breeders and owners can contribute to healthier dogs and improved long-term welfare.
